ACIU
Price
$2.56
Change
+$0.11 (+4.49%)
Updated
Jun 26 closing price
Capitalization
260.54M
33 days until earnings call
Intraday BUY SELL Signals
AMLX
Price
$17.79
Change
+$0.35 (+2.01%)
Updated
Jun 26 closing price
Capitalization
1.98B
40 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACIU vs AMLX

ACIU vs AMLX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ACIU vs. AMLX commentary
Jun 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACIU is a StrongBuy and AMLX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2026
Stock price -- (ACIU: $2.56 vs. AMLX: $17.79)
Brand notoriety: ACIU and AMLX are both not notable
ACIU represents the Biotechnology, while AMLX is part of the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ACIU: 92% vs. AMLX: 261%
Market capitalization -- ACIU: $260.54M vs. AMLX: $1.98B
ACIU [@Biotechnology] is valued at $260.54M. AMLX’s [@Pharmaceuticals: Generic] market capitalization is $1.98B. The market cap for tickers in the [@Biotechnology] industry ranges from $124.7B to $0. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACIU’s FA Score shows that 0 FA rating(s) are green whileAMLX’s FA Score has 0 green FA rating(s).

  • ACIU’s FA Score: 0 green, 5 red.
  • AMLX’s FA Score: 0 green, 5 red.
According to our system of comparison, AMLX is a better buy in the long-term than ACIU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACIU’s TA Score shows that 5 TA indicator(s) are bullish while AMLX’s TA Score has 6 bullish TA indicator(s).

  • ACIU’s TA Score: 5 bullish, 4 bearish.
  • AMLX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, AMLX is a better buy in the short-term than ACIU.

Price Growth

ACIU (@Biotechnology) experienced а +6.67% price change this week, while AMLX (@Pharmaceuticals: Generic) price change was +13.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.08%. For the same industry, the average monthly price growth was +1.67%, and the average quarterly price growth was +1916.03%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.11%. For the same industry, the average monthly price growth was +1.35%, and the average quarterly price growth was +10.85%.

Reported Earning Dates

ACIU is expected to report earnings on Jul 30, 2026.

AMLX is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+4.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Generic (+1.11% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($1.98B) has a higher market cap than ACIU($261M). AMLX YTD gains are higher at: 47.268 vs. ACIU (-18.471). ACIU has higher annual earnings (EBITDA): -66.02M vs. AMLX (-158.8M). AMLX has more cash in the bank: 280M vs. ACIU (74.8M). ACIU has less debt than AMLX: ACIU (4.3M) vs AMLX (5.63M). ACIU has higher revenues than AMLX: ACIU (3.7M) vs AMLX (0).
ACIUAMLXACIU / AMLX
Capitalization261M1.98B13%
EBITDA-66.02M-158.8M42%
Gain YTD-18.47147.268-39%
P/E RatioN/A2.69-
Revenue3.7M0-
Total Cash74.8M280M27%
Total Debt4.3M5.63M76%
FUNDAMENTALS RATINGS
ACIU: Fundamental Ratings
ACIU
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
79
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACIUAMLX
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 6 days ago
72%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 20 days ago
86%
Bearish Trend 20 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ACIU
Daily Signal:
Gain/Loss:
AMLX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
UMEMX22.06N/A
N/A
Columbia Emerging Markets Inst
IICAX12.11N/A
N/A
AMF Large Cap Equity AMF
AAWEX21.71N/A
N/A
Cavanal Hill World Energy & Power A
TALCX18.73N/A
N/A
Transamerica Large Cap Value R6
JHURX52.99N/A
N/A
JPMorgan Emerging Markets Equity R3

ACIU and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACIU has been loosely correlated with KURA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ACIU jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACIU
1D Price
Change %
ACIU100%
+4.49%
KURA - ACIU
35%
Loosely correlated
+5.12%
AMLX - ACIU
33%
Loosely correlated
+2.01%
PCVX - ACIU
31%
Poorly correlated
+5.29%
EDIT - ACIU
31%
Poorly correlated
+4.38%
XNCR - ACIU
31%
Poorly correlated
+2.37%
More

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
+2.01%
XOMAO - AMLX
68%
Closely correlated
-0.02%
XOMAP - AMLX
51%
Loosely correlated
+0.12%
OCUL - AMLX
46%
Loosely correlated
+0.77%
LRMR - AMLX
45%
Loosely correlated
+4.57%
JAZZ - AMLX
43%
Loosely correlated
+1.69%
More